Manfred Maitz

Dr. Manfred Maitz serves as a Research Fellow and Group Leader at the Leibniz Institute of Polymer Research Dresden (IPF), specifically within the Max Bergmann Center of Biomaterials under the Division Polymer Biomaterials Science. He holds a secondary appointment as Guest Professor at Southwest Jiaotong University's School of Materials Science and Engineering in Chengdu, China, where he conducts annual research stays. His career spans institutions in Würzburg, Ulm, Magdeburg, Dresden, and Chengdu since the early 2000s.

Dr. Maitz's research centers on hemocompatible surfaces for blood-contacting medical devices, with focus on feedback-responsive materials that regulate blood coagulation and inflammatory responses. His work targets critical applications including vascular stents, artificial heart valves, hemodialysis membranes, and extracorporeal circulation tubings. Recent publications demonstrate leadership in developing FXa-responsive hydrogels, heparin-releasing coatings, and platelet-mimetic surfaces that dynamically interact with blood components.

Analysis of his 15 most recent articles (2023-2025) reveals dominant themes in stimuli-responsive anticoagulation, biomimetic surface engineering, and blood-material interaction mechanisms. His team frequently employs hydrogel-based delivery systems triggered by coagulation factors, with increasing focus on cancer-biomaterial interfaces and advanced in vitro blood models. Methodologically, his work bridges polymer chemistry, surface science, and translational hematology.

As a recognized expert, he participates in the WTR (Working Group on Thrombosis and Hemostasis Research) at IPF and maintains active memberships in major societies including the Society for Biomaterials, German Society for Biomaterials, American Heart Association, and International Society on Thrombosis and Haemostasis. While specific awards aren't documented in the source material, his sustained leadership in high-impact journals like Nature Communications, Biomaterials, and Advanced Science underscores significant contributions to the field.

Dr. Maitz's collaborative network spans Germany, China, and international institutions, with frequent co-authorship on vascular biomaterial projects. His group develops specialized in vitro blood flow models and hemocompatibility testing platforms that address limitations of static assays. Current work emphasizes clinical translation of responsive coatings for neurovascular implants and pancreatic cancer microenvironment modeling.